Maravai LifeSciences Reports Q3 2026 Financial Results
Maravai LifeSciences Holdings, Inc. announced its financial results for the third quarter ended September 30, 2026. Total revenue increased 10% year-over-year, while mRNA revenue grew 28%. The company highlighted its continued growth in life science reagents and services to researchers and biotech innovators.